11C-甲基-L-甲硫氨酸PET测量参数鉴别脑转移瘤肿瘤进展与放射性改变
回顾性纳入26例31个脑转移灶,因影像学不确定进展而行MET-PET,以至少4个月临床影像随访为参考标准,比较各测量参数鉴别肿瘤进展与放射性改变的能力。除代谢肿瘤体积外,各MET-PET参数在两组间差异均有统计学意义,SUVmax的AUC最高为0.834,最佳阈值为3.29,对应敏感度78.57%、特异度70.59%、阳性预测值74.32%、阴性预测值75.25%。结论认为MET-PET对诊断脑转移瘤放射性改变有用,SUVmax诊断效能最佳。
要点
- MET-PET各参数中SUVmax诊断效能最高,AUC为0.834,最佳阈值为3.29。
- SUVmax阈值3.29对应敏感度78.57%、特异度70.59%、阳性预测值74.32%、阴性预测值75.25%。
- 除代谢肿瘤体积外,各MET-PET参数在肿瘤进展与放射性改变间差异均有统计学意义。
核心结论
- MET-PET是诊断脑转移瘤放射性改变的有用方法,SUVmax是诊断效能最高的PET参数。
研究设计与样本
- 回顾性队列研究,纳入26例患者共31个转移性病灶,均因影像学不确定疾病进展而行PET扫描;以PET扫描后至少4个月临床影像随访确立放射性改变或肿瘤进展的最终诊断;分析SUVmean、SUVmax、SUVpeak、T/Nmean、T/Nmax-mean、T/Npeak-mean、代谢肿瘤体积和总病灶甲硫氨酸代谢等参数。
诊断标准与关键数值
- 除代谢肿瘤体积外,所有MET-PET参数在肿瘤进展与放射性改变病灶间差异均有统计学意义;SUVmax的AUC最高为0.834,最佳阈值为3.29,对应敏感度78.57%、特异度70.59%、阳性预测值74.32%、阴性预测值75.25%。
临床应用与阅片要点
- 作者指出,更稳健地比较SUVmax与SUVpeak可能有助于改进随访治疗计划。
局限性
- 原文指出关于脑转移瘤放射性改变诊断中最佳PET测量参数的最小文献存在。
- 原文结论提出更稳健地比较SUVmax与SUVpeak可能有助于改进随访治疗计划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Radiation-induced changes (RIC) secondary to focal radiotherapy can imitate tumour progression in brain metastases and make follow-up clinical decision making unreliable. 11C-methyl-L-methionine-PET (MET-PET) is widely used for the diagnosis of RIC in brain metastases, but minimal literature exists regarding the optimum PET measuring parameter to be used. We analysed the diagnostic performance of different MET-PET measuring parameters in distinguishing between RIC and tumour progression in a retrospective cohort of brain metastasis patients.
METHODS: 26 patients with 31 metastatic lesions were included on the basis of having undergone a PET scan due to radiological uncertainty of disease progression. The PET images were analysed and methionine uptake quantified using standardised-uptake-values (SUV) and tumour-to-normal tissue (T/N) ratios, generated as SUVmean, SUVmax, SUVpeak, T/Nmean, T/Nmax-mean and T/Npeak-mean. Metabolic-tumour-volume and total-lesion methionine metabolism were also computed. A definitive diagnosis of either RIC or tumour progression was established by clinicoradiological follow-up of least 4 months subsequent to the investigative PET scan.
RESULTS: All MET-PET parameters except metabolic-tumour-volume showed statistically significant differences between tumour progression and lesions with RIC. Receiver-operating-characteristic curve and area-under the-curve analysis demonstrated the highest value of 0.834 for SUVmax with a corresponding optimum threshold of 3.29. This associated with sensitivity, specificity, positive predictive and negative predictive values of 78.57, 70.59%, 74.32 and 75.25% respectively.
CONCLUSIONS: MET-PET is a useful modality for the diagnosis of RIC in brain metastases. SUVmax was the PET parameter with the greatest diagnostic performance.
ADVANCES IN KNOWLEDGE: More robust comparisons between SUVmax and SUVpeak could enhance follow-up treatment planning.
引用
- Govaerts CW, van Dijken BR, Stormezand GN, et al. 11C-methyl-L-methionine PET measuring parameters for the diagnosis of tumour progression against radiation-induced changes in brain metastases. Br J Radiol. 2021. PMID: 34233489. doi:10.1259/bjr.20210275
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。